LITHIUM CARBONATE

Alembic Pharmaceuticals Inc.🇺🇸 United States

FDA Page

Effective Date: Nov 3, 2022
Approval ID: 4ca2b977-b94c-4232-9b7e-835db97c9544
Products: 3 registered
Version: 10

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LITHIUM CARBONATE CAPSULES safely and effectively. See full prescribing information for LITHIUM CARBONATE CAPSULES. LITHIUM CARBONATE capsules, for oral use Initial U.S. Approval: 1970

Quick Stats

Total Products3

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.